Emergency Patient Articles & Analysis

COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...

By Neurescue

TOPIC: E-health Adoption and Outcomes To-Date at Alberta Health Services Plenary Session 8 Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Tuesday, April 5 2011 at 9:45 a.m WHERE: Toronto Priority Code: 3BL1 Featuring: William Trafford, Senior Vice-President, Corporate Merger and Information Technology, Alberta Health Services How is Alberta Health ...

By 3BL Media

The intent of this guide is to identify the general performance and good practice standards that a pelvic ring circumferential compression stabilization device (PRCCSD) should possess. Currently, a number of base platforms such as full-body spinal immobilization devices (long boards) are used to immobilize patients during transport and before definitive treatment. These platforms limit gross ...

By ASTM International

Today, xCures announced that they will present two posters at the 27th Annual Meeting of the Society for Neuro-Oncology, from the 16th to the 20th of November 2022, in Tampa Bay, Florida. The Society for Neuro-Oncology is a multidisciplinary society of healthcare professionals dedicated to promoting advances in neuro-oncology through research and education. Their annual meeting features research ...

By xCures

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, ...

By Asensus Surgical US, Inc.

Anuncia Inc., an emerging leader in Cerebral Spinal Fluid (CSF) management, received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its ReFlow™ System Mini intended for the treatment of CSF disorders requiring shunting such as hydrocephalus, a debilitating and life-threatening condition affecting more than 1 million U.S. patients. Elsa Abruzzo, President of ...

By Anuncia Medical, Inc.

Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its ...

By BrainScope Company, Inc.

Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose 4, potentially reducing the time to reach maintenance by several weeks NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology ...

By Intrommune Therapeutics

BrainScope today announced a new system-wide agreement with Yankee Alliance to make BrainScope’s innovative point-of-care neuro-technology system available to the 18,000 members, including over 5000 outpatient facilities and senior centers, in Yankee Alliance. BrainScope is the only FDA cleared medical device that aids in the objective triage of head injured patients for suspected mild ...

By BrainScope Company, Inc.

Thermo Fisher Scientific will host a symposium featuring customer presentations that highlight the latest efforts in tumor mutation burden (TMB) standardization by its European consortium, and clinical research data focused on the application of this emerging biomarker to help guide selection of immunotherapies. The talks will take place Sept. 10 during the 30th European Congress of Pathology ...

By Thermo Fisher Scientific, LIMS & Laboratory Software

BrainScope, a medical neurotechnology company that is a pioneer in the use of A.I. and machine learning in the creation of biomarkers of brain injuries and disease was selected from five finalists as the company with the most commercial potential at the 5th Annual BioHealth Capital Region Crab Trap Competition. The Bethesda, Maryland based company is helping hospital Emergency Departments (EDs) ...

By BrainScope Company, Inc.

Gouda - Imtech N.V. (technical services provider in Europe) announces that it has been awarded orders worth over 130 million euro in the care & cure sector in Germany. Innovation is the key word here. Imtech is involved in various innovations relating to ventilation, energy efficiency, ultra clean air in operating theatres and the use of medical gases.  René van der Bruggen, CEO Imtech: ...

By Thomson Reuters

At best, most of us tolerate needles. Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. On the other side of the spectrum, there are people with such an intense fear of needles that they are considered to have a phobia, trypanophobia to be precise. Many articles have been ...

By Medsource Labs

A combination of upgrading and enforcement of infection prevention standards coupled with an expanding volume of hospital, surgical and outpatient procedures will promote overall gains in the global market for disposable medical supplies. Disposable medical gloves, a segment of this market, will continue to flourish despite increasing raw material costs and severe cost-cutting measures in the ...

By Global Information, Inc. (GII)

Broomfield Colorado 6/25/2022. Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...

By Aktiv Pharma Group, Inc

Revolutionary bleeding control technology will now be available in Europe and other International markets. RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe. Unlike traditional wound treatments that may take several ...

By RevMedx

AIS with collaboration with Johnson & Johnson Institute has launched a special website dedicated to internal and external content to help healthcare workers keep up on the latest news on COVID-19. The site features: Webinars presented by physicians and leaders in the battle against COVID-19 The New Normal in Elective Surgery Thoracic Surgery on the Frontline of COVID-19 Managing ...

By Auris Health, Inc.

A Boston neurosurgeon recently avoided doing emergency brain surgery on a young patient just by pressing on a new device. The Alivio ReFlow ventricular system was embedded beneath the scalp of the unidentified hydrocephalus patient. Comprised of a subcutaneous “flusher” component and a ventricular catheter, the device has a “relief membrane” backup feature at the ...

By Anuncia Medical, Inc.

Novant Health’s integration of Aidoc’s AI solutions, amid the latest wave of the Omicron variant, expands upon its existing slate of innovative technologies designed to improve delivery of patient care and outcomes Aidoc, the leading provider of enterprise-grade AI solutions for medical imaging, announces a partnership with Novant Health, a health network of over 1,800 physicians ...

By Aidoc

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary arteries and for ...

By AngioDynamics, Inc.